AIM2 can be used as an adjuvant for DNA vaccines in viral infections or tumors, then recognizes DAMPs, produces inflammatory cytokines, and enhances the proliferation and function of CD8+ T cells. The gene discussed is CD8A; the disease is viral infectious disease.